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Two Cases of Seasonal Influenza Virus (H3N2) and Acute Respiratory Distress 
Syndrome
Moo Hyun Kim, Bo Ra Yoon, Myung Jin Song, Ji Soo Choi, Sang Hoon Lee, Kyung Soo Chung
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Institute of Chest Diseases, Severance Hospital, Yonsei University College 
of Medicine, Seoul, Korea
Compared with the 2009 pandemic influenza A (H1N1), the seasonal influenza A (H3N2) in 2011–2012 was self-limited and mild. 
However, some cases proceeded to acute respiratory distress syndrome (ARDS) due to underlying medical history. Here we report 
two cases with influenza A (H3N2) progressing to fatal ARDS. One case with several underlying medical conditions eventually died 
from multi-organ failure despite the application of extracorporeal membrane oxygenation. When patients are suspected to have 
influenza, it is imperative to investigate their medical histories and risk factors. If they have many co-morbidities or risk factors, clini-
cians should initiate aggressive management immediately regardless of the type of influenza infection.
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INTRODUCTION
Influenza viruses are major causes of lower respiratory tract in-
fections. Three inﬂuenza pandemics occurred during the 20th 
century. The ‘Spanish ﬂu’ pandemic A (H1N1) emerged in 1918–
1919, and the second pandemic influenza A (H2N2) occurred in 
1957–1958. In 1968, a new type A (H3N2) appeared and became 
epidemic [1]. Pandemic influenza virus A (H1N1) 2009 is associat-
ed with a higher risk of viral pneumonia than seasonal influenza 
virus A (H3N2). Most H3N2—seasonal influenza A (2011–2012) 
patients experienced mild, self-limited influenza-like illness. 
However, some patients were at increased risk for influenza com-
plications such as severe pneumonia and acute respiratory distress 
syndrome (ARDS) due to old age or underlying medical history 
[2]. Recently, several reports have noted that the seasonal influen-
za virus A (H3N2) caused severe respiratory infection and induced 
diffuse alveolar damage in some patients during the influenza epi-
demic season 2011–2012 [3]. Here, we report the first two cases of 
ARDS caused by seasonal influenza virus A (H3N2) in Korea.
CASE REPORTS
1. Case report 1
A 50-year-old man who had experienced two days of cough, 
sputum, fever, and myalgia visited Severance Hospital emergency 
room via the local medical center. The patient had been diagnosed 
with rheumatic mitral stenosis and aortic regurgitation in 2010, 
and underwent mitral valve and aortic valve replacement. His 
other past history included diabetes mellitus, Behcet’s disease, and 
atrial fibrillation. He did not receive the influenza vaccination on 
the day of admission. Chest computed tomography (CT) revealed 
both lower and right upper lobe pneumonic consolidation (Fig. 
1A, C). Initial vital signs included high fever spiking (blood pres-
sure, 145/79 mm Hg; heart rate, 89 rate/min; body temperature, 
38.4°C) and laboratory studies revealed elevated inflammatory 
markers (C-reactive protein, 222.6 mg/L [normal range, 0 to 8 mg/
L]). He was admitted for treatment of health care associated pneu-
monia and we started antibiotics and oseltamivir empirically (75 
mg twice per day for 5 days). However, the patient’s clinical condi-
tion continued to worsen, so he was transferred to the intensive 
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care unit (ICU). With clinical and radiological signs of ARDS pro-
gression, he was intubated and started mechanical ventilator care 
on hospital day 2. Ventilator settings followed standard lung-pro-
tective strategies (tidal volume 6 mL/kg of predicted ideal body 
weight with plateau pressure lower than maximum 30 cm H2O) 
[4]. Echocardiography showed a well-functioning prosthetic valve 
and his ejection fraction (EF) was 69% within normal range. For 
influenza virus identification, we collected sputum by fiber-optic 
bronchoscopy and analyzed the sample using Advansure TM RV 
real-time reverse transcription-polymerase chain reaction (PCR; 
LG Life Science, Daejeon, Korea). PCR assays of nasal swab and 
bronchoalveolar lavage samples were positive for viral genomes of 
the H3N2 virus. Despite high fraction of inspired oxygen (FiO2) 
supply and rescue therapy including prone positioning and re-
cruitment maneuvers, the patient’s hypoxia was not resolved, and 
therefore three days after admission extracorporeal membrane 
oxygenation (ECMO) treatment was started using the Capiox 
emergency bypass system (emergency bypass system; Terumo 
Inc., Tokyo, Japan). Despite the application of ECMO, the patient 
showed septic exacerbation with fevers of up to 39°C, increased 
laboratory markers of inflammation (C-reactive protein, 352 mg/
L [normal range, 0 to 8 mg/L]; procalcitonin, 80.44 ng/mL [nor-
mal range, 0 to 0.5 ng/mL]), which revealed the presence of hepati-
tis and pancytopenia (aspartate aminotransferase, 1,222 IU/L 
[normal range, 13 to 34 IU/L]; alanine aminotransferase, 466 IU/L 
[normal range, 5 to 46 IU/L]; white blood cell [WBC], 1.97×103/uL 
[normal range, 4.0 to 10.8 103/μL]; hemoglobin, 9.7 g/dL [normal 
range, 13.0 to 17.4 g/dL]; platelet count, 56×103/μL [normal range, 
150 to 400 103/μL]). Chest X-ray showed aggravated pulmonary 
infiltration and the EF was decreased by 31%, so we exchanged ve-
no-venous ECMO for veno-arterial ECMO due to low oxygen-
ation (Fig. 2A, C). Treatment with specific antiviral drugs was un-
successful and the patient developed multiple organ failure. After 
3 days of ECMO, the patient died.
2. Case report 2
A 37-year-old male patient had a cough, fever as high as 39.5°C, 
and dyspnea that did not improve despite medication for a period 
Fig. 1. Chest CT of chest. (A, C) A chest CT of case 1 evaluated upon admission show multifocal consolidation in both lungs and lobar consolidation in right middle 
lungs. (B, D) A chest CT of case 2 taken upon admission reveal lobular, peribronchial and subpleural consolidation in both lungs. CT, computed tomography.
A B C D
Fig. 2. Chest radiographs of two cases at hospital day 1 and 7. (A, C) Chest radiograph of case 1. A chest X-ray taken upon ICU admission show consolidation of right 
middle lobe. Despite ICU care, the patient’s condition get worsened. Chest X-ray on ICU day 7 show progression of consolidation. (B, D) Chest radiograph of case 2. A 
chest X-ray taken on ICU admission reveal bilateral infiltrates. Chest X-ray taken on ICU day 7 reveal marked resolution of consolidation. ICU, intensive care unit. PA, 
posterior-anterior; RT, right.
A B C D
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of 10 days. He was admitted to a local hospital for 4 days. He had 
no co-morbidities or any other relevant past history. He had not 
been vaccinated against influenza that year. His clinical condition 
had been worsening, so the patient was referred to the emergency 
department. Initial vital signs were stable (blood pressure, 103/62 
mm Hg; heart rate, 96 rate/min; body temperature, 36.9°C) and 
laboratory study revealed hypoxia (arterial oxygen partial pres-
sure [PaO2], 56.9 mm Hg [normal range, 83 to 108 mm Hg]), bicy-
topenia (WBC, 1.70×103/μL [normal range, 4.0 to 10.8 103/μL]; 
platelet count 53×103/μL [normal range, 150 to 400 103/μL]), and 
inflammatory marker elevation (C-reactive protein, 198.1 mg/L 
[normal range, 0 to 8 mg/L]). CT-scans performed after arriving at 
the emergency department showed extensive pneumonic consoli-
dations, mostly in both lower lobes (Fig. 1B, D), so we started the 
patient on antibiotics and oseltamivir (75 mg twice per day for 5 
days) empirically. Despite initial management, the patient’s gas 
exchange continued to worsen (PaO2/FIO2 at admission=56.9 
mm Hg) and he showed respiratory fatigue. Therefore, we pro-
ceeded to intubation and started mechanical ventilation. Bron-
choalveolar lavage PCR for influenza virus A (H3N2) was positive 
and other bacterial etiology was negative. Despite high positive 
end expiratory pressure levels the patient’s severe hypoxemia per-
sisted, and therefore the next day the patient was shifted to the 
prone position. After changing the patient to the prone position, 
oxygenation was improved. Two days after ICU admission the pa-
tient’s clinical condition improved and pneumonic consolidation 
was resolved (Fig. 2B, D), so we started a weaning trial and extu-
bated the patient 7 days after ICU admission. He was able to main-
tain spontaneous breathing and was discharged after 18 days of 
admission in the ICU.
DISCUSSION
This is the first case report of seasonal influenza A (H3N2) lead-
ing to severe ARDS in Korea. The pathogenesis of ARDS is known 
to include the influenza virus, starting with the breakdown of the 
epithelial-endothelial barrier, fluid leakage into the alveoli, and 
leading eventually to respiratory failure [5]. Many patients experi-
enced progression to severe lower respiratory infections during 
the 2009 influenza A (H1N1) pandemic period, and required 
treatment with rescue therapy, like prone positioning, recruitment 
maneuvers, and ECMO due to ARDS. Although most cases of 
seasonal influenza (H3N2) usually follow a benign course and are 
self-limited, some cases of influenza-H3N2 proceed to severe 
ARDS. There were two cases of seasonal influenza (H3N2) devel-
oping to ARDS in 2011–2012 reported in Italy (Table 1) [3]. This 
previous study found that patients with several relevant past medi-
cal history factors tended to have poor prognosis. In 2014–2015, an 
additional report described two cases of severe lower respiratory 
infection due to subtype H3N2 and progression to ARDS (Table 
2). In these cases, the H3N2-influenza virus may also have influ-
enced the endothelial-epithelial barrier, and generated alveolar 
Table 1. Cases of influenza-H3N2 induced acute respiratory distress syndrome
Patient Age (yr) Sex Initial clinical manifestation Pathogen Underlying disease Treatment Outcome
Case 1 50 Male Cough, sputum, fever, myalgia Influenza A-H3N2 Valvular heart disease, behcet 
   disease, diabetes mellitus
Oseltamivir 150 mg twice per 
   day for 5 days
Death
Case 2 37 Male Fever, cough, dyspnea Influenza A-H3N2 None Oseltamivir 150 mg twice per 
   day for 5 days
Survival
Case 3 (Italy) [3] 66 Male Cough, sneezing Influenza A-H3N2 Rheumatoid arthritis, sjogren 
   syndrome
Oseltamivir 20 mg twice per day Death
Case 4 (Italy) [3] 76 Male Fever, cough, dyspnea Influenza A-H3N2 Diabetes mellitus, arteriopathy Oseltamivir 20 mg twice per day Survival
Table 2. Initial patient characteristics
Patient Sex/age (yr)
Ejection
fraction (%) at 
ICU admission
Charlson
co-morbidity 
index
Initial PaO2/FiO2a) 
at ICU admission 
(mm Hg)
Mechanical 
ventilation
period (day)
Extracorporeal 
membrane 
oxygenation 
application
Duration of 
ICU stay (day)
Sequential 
organ failure 
assessment 
score
Acute physiology 
and chronic health 
evaluation II score
Outcome
Case 1 Male/50 61 3 108 7 Yes 7 14 23 Death
Case 2 Male/37 60 0 56.9 6 None 8 12 17 Survival
ICU, intensive care unit.
a)Arterial oxygen partial pressure/fraction of inspired oxygen.
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Fig. 3. Progress outlines of two cases. (A) Case 1. (B) Case 2. PCR, polymerase chain reaction; CRRT, continuous renal replacement therapy; Prone, prone position; 
vvECMO, veno-venous extracorporeal membrane oxygenation; vaECMO, veno-arterial extracorporeal membrane oxygenation; IVIG, intravenous immunoglobulin; Pip/
tazo, piperacillin/tazobactam.
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damage when patients had multiple risk factors, thereby leading to 
ARDS. According to World Health Organization guidelines, anti-
viral drug therapy can be beneficial when initiated early and at 
higher doses for longer durations [6]. Fatal cases of influenza usu-
ally feature secondary bacterial lung infections, so treatment with 
pneumococcal vaccination should be considered [7]. Our cases in-
dicate that high Charlson co-morbidity index, sequential organ 
failure assessment score, and acute physiology and chronic health 
evaluation II score were associated with poor prognosis (Table 2). 
The late initiation of oseltamivir was also associated with poor re-
sponse, even in a young patient (Fig. 3). The current cases support 
the observation that if a patient with many underlying medical 
conditions shows influenza symptoms, oseltamivir should be ad-
ministered as soon as possible without waiting for the results of 
laboratory tests [8], and we should consider higher doses. Also 
routine screening for virologic markers is required [9].
In conclusion, influenza cannot be ruled out as a cause of severe 
lower respiratory tract infection. The cases described here indicate 
that influenza A (H3N2) viruses can cause ARDS associated with 
significant morbidity and mortality. When patients are suspected 
to have influenza, it is important to investigate relevant medical 
history and risk factors. If patients have numerous co-morbidities 
or risk factors, they should be observed carefully and started on 
aggressive management such as higher doses and longer duration 
as soon as possible regardless of the type of influenza infection. In 
the future, studies regarding specific risk factors associated with 
ARDS progression due to influenza A (H3N2) are warranted.
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